These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32316074)

  • 21. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of under-reporting of adverse drug reactions: a systematic review.
    Lopez-Gonzalez E; Herdeiro MT; Figueiras A
    Drug Saf; 2009; 32(1):19-31. PubMed ID: 19132802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).
    Biagi C; Montanaro N; Buccellato E; Roberto G; Vaccheri A; Motola D
    Eur J Clin Pharmacol; 2013 Feb; 69(2):237-44. PubMed ID: 22706618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?
    Bäckström M; Mjörndal T
    Eur J Clin Pharmacol; 2006 May; 62(5):381-5. PubMed ID: 16572320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
    Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
    Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
    Seid MA; Kasahun AE; Mante BM; Gebremariam SN
    Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
    Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
    Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical students as adverse drug event managers, learning about side effects while improving their reporting in clinical practice.
    Reumerman M; Tichelaar J; Richir MC; van Agtmael MA
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1467-1476. PubMed ID: 33666715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reporting of adverse drug reactions by hospital doctors and the response to intervention.
    McGettigan P; Golden J; Conroy RM; Arthur N; Feely J
    Br J Clin Pharmacol; 1997 Jul; 44(1):98-100. PubMed ID: 9241104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting of adverse drug reactions by general practitioners: a questionnaire-based study in the Netherlands.
    Passier A; ten Napel M; van Grootheest K; van Puijenbroek E
    Drug Saf; 2009; 32(10):851-8. PubMed ID: 19722728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breastfeeding Knowledge and Attitudes of Nevada Health Care Professionals Remain Virtually Unchanged over 10 Years.
    Sigman-Grant M; Kim Y
    J Hum Lact; 2016 May; 32(2):350-4. PubMed ID: 26446097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatrists.
    Castberg I; Reimers A; Sandvik P; Aamo TO; Spigset O
    Nord J Psychiatry; 2006; 60(3):227-33. PubMed ID: 16720514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
    Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
    Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients' experiences on adverse drug reactions reporting: a qualitative study.
    Al Dweik R; Yaya S; Stacey D; Kohen D
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1723-1730. PubMed ID: 32661571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update.
    García-Abeijon P; Costa C; Taracido M; Herdeiro MT; Torre C; Figueiras A
    Drug Saf; 2023 Jul; 46(7):625-636. PubMed ID: 37277678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.